Article Information
History
- June 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jonathan J. Mandolo1,2,
- Marc Y. R. Henrion1,3,
- Chimwemwe Mhango1,2,
- End Chinyama1,
- Richard Wachepa1,
- Oscar Kanjerwa1,
- Chikondi Malamba-Banda1,2,4,
- Isaac T. Shawa1,5,
- Daniel Hungerford4,6,
- Arox W. Kamng’ona1,3,
- Miren Iturriza-Gomara4,6,7,
- Nigel A. Cunliffe4,6 and
- Khuzwayo C. Jere1,4,6,#
- 1Malawi – Liverpool – Wellcome Trust Clinical Research Programme, Blantyre, Malawi
- 2Department of Biomedical Sciences, Kamuzu University of Health Sciences, Blantyre, Malawi
- 3Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
- 4Centre for Global Vaccine Research, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK
- 5Department of Medical Laboratory Sciences, Kamuzu University of Health Sciences, Blantyre, Malawi
- 6NIHR Health Protection Research Unit in Gastrointestinal Infections, University of Liverpool, UK
- 7Center for Vaccine Innovation and Access, PATH
- ↵#Corresponding author
: Dr Khuzwayo C. Jere, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, United Kingdom. Tel: +44 151 795 9614, Fax: +44 151 795 5529, Email: Khuzwayo.Jere{at}liverpool.ac.uk